Havrix Hepatitis A adult vaccine 1440 EL.U./ml

Strengths available : 1440 EL.U./ml

Form :  Injection and suspension

Storage :Store at 2 to 8°C.

Is the medicine US FDA approved : Yes

Date of Approval : 17 October 2005

Dosage : Children and Adolescents: Primary immunization for children and adolescents (12 months through 18 years of age) consists of a single 0.5-mL dose and a 0.5-mL booster dose administered anytime between 6 and 12 months later in order to ensure the highest antibody titers. The preferred sites for intramuscular injections are the anterolateral aspect of the thigh in infants and young children or the deltoid muscle of the upper arm in older children.

Adults: Primary immunization for adults consists of a single 1-mL dose and a 1-mL booster dose administered anytime between 6 and 12 months later in order to ensure the highest antibody titers. In adults, the injection should be given in the deltoid region.

More Common side effects are Fever more than 99.5 degrees F,general feeling of discomfort or illness,unusual tiredness or weakness.

Rare side effects are Body aches or pain,chills,congestion,cough,difficulty with breathing or swallowing,dryness or soreness of the throat,ear congestion,headache,hives,hoarseness,itching especially of the feet or hands,loss of voice,nasal congestion,reddening of the skin, especially around the ears,runny nose,shortness of breath,sneezing,sore throat,swelling of the eyes, face, or inside of the nose,swollen, painful, or tender lymph glands in the neck, armpit, or grointender, swollen glands in the neck,tightness in the chest,unusual tiredness or weakness (sudden and severe),voice changes,wheezing.

Pack of 1 vial